Decibel Therapeutics

1325 Boylston Street
Suite 500
Boston
Massachusetts
02215
United States

Tel: 617-370-8701

Email: info@decibeltx.com

Show jobs for this employer

About Decibel Therapeutics

Decibel Therapeutics is a hearing company focused on discovering and developing new therapies to protect, repair and restore hearing. By combining recent innovations in hearing science with leading diagnostic tools, biological insights, modeling and therapeutic delivery techniques, Decibel is pioneering a comprehensive approach to define the underlying biological causes of hearing loss and develop a pipeline of breakthrough therapies targeted to specific indications and populations. Founded by the world’s preeminent experts in hearing loss, Decibel Therapeutics was launched in 2015 by Third Rock Ventures and is headquartered in Cambridge, Mass.
YEAR FOUNDED:
2015
LEADERSHIP:
President and CEO: Steven Holtzman
CMO: Leslie Shinobu, M.D., Ph.D.
Vice President, Pharmacology: Ada Silos-Santiago, Ph.D.
RECENT FUNDING:
October 15, 2015: $52 Million Series A From GlaxoSmithKline, SR One and Third Rock Ventures.
JOB OPPORTUNITY:
https://decibeltx.com/careers/

25 articles with Decibel Therapeutics